Cryptococcosis in HIV-seronegative patients is rarely reported from India. This prospective study was conducted to look for cryptococcal meningitis in HIV-seronegative individuals and compare their laboratory features to cryptococcal meningitis in HIV-seropositive patients. Cerebrospinal fl uid was collected from 153 suspected cases of meningitis and subjected to India ink preparation, antigen detection, and culture. Nineteen samples tested positive for Cryptococcus neoformans infection. Seventeen and two patients were HIV reactive and nonreactive, respectively. In vitro susceptibility of C. neoformans isolates to fl uconazole and amphotericin B was performed using standard broth microdilution method and E-test. Eighteen strains were susceptible to amphotericin B, while fl uconazole was reported susceptible in 15 strains. Hence, index of suspicion of C. neoformans infection as possible cause of meningitis must be maintained even in HIV-negative patients. Use of amphotericin B for treating C. neoformans meningitis should be restricted to prevent any increase in resistance.
INTRODUCTION
Cryptococcus neoformans is an encapsulated yeast-like organism causing infections worldwide. [1] Inhalational route is the major route of transmission of cryptococcosis besides local transmission through skin and eyes. [2] C. neoformans causes human diseases ranging from asymptomatic colonization to severe meningitis and disseminated infection. [1] Nevertheless, central nervous system is the most common site of cryptococcal infection. Cryptococcal meningitis is the most fatal form of cryptococcosis. [3] Recent data indicate that the occurrence of cryptococcal infection is high in the developing nations including India. [3, 4] Cryptococcosis is generally found in association with acquired immunodeficiency syndrome (AIDS) although it has been reported to sometimes cause disease in HIV-seronegative patients as well. [1] There are very few reports of cryptococcosis in HIV-seronegative patients from India. [3, 5] Here, we report four cases of cryptococcal meningitis in HIV-seronegative individuals from a 1800-bed tertiary care hospital in Delhi and their laboratory diagnostic features in comparison to cryptococcal meningitis in HIV-seropositive patients.
MATERIALS AND METHODS
This was a prospective study conducted on cerebrospinal fluid (CSF) samples received in the Department of Microbiology at a 1800-bed tertiary care hospital in Delhi from clinically suspected cases of meningitis during a 3-year period from December 2012 to December 2015. Human ethical clearance was obtained from the institute. Written informed consent was taken from the study participants.
Four to five milliliters of CSF was collected from each patient. CSF was centrifuged at 2000 g for 1 min, and the supernatant stored at −20°C for antigen detection. The CSF sample was subjected to India ink preparation and rapid antigen detection. Antigen detection was done by using commercial kit, IMMY, CrAg lateral flow immunochromatographic assay (Germany). The CSF sample was also cultured following standard techniques on Sabouraud dextrose agar without cycloheximide but with antibiotics, along with birdseed agar, followed by incubation at 25°C. [6] Access this article online Website: www.ijpmonline.org This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
For reprints contact: reprints@medknow.com

Antifungal susceptibility testing
In vitro susceptibility of C. neoformans isolates to fluconazole and amphotericin B was performed using the standard broth microdilution method as recommended by the CLSI M27-A3 protocol. [7] Quality control strains included were Candida parapsilosis ATCC 22019 and Candida krusei ATCC 6258. Fluconazole and amphotericin B were obtained as powder from HiMedia, Mumbai, and Sigma-Aldrich, Mumbai, respectively. Stock solutions of fluconazole and amphotericin B were prepared in sterile distilled water and dimethyl sulfoxide, respectively. Stock solutions were diluted with RPMI 1640 (RPMI tissue culture medium supplemented with glutamine) (Sigma-Aldrich, Mumbai) with 2% glucose, buffered to pH 7.0 with 0.156M 3-n-morpholinopropane-sulfonic acid (Sigma-Aldrich, Mumbai). The final concentrations were 0.12-64 μg/l and 0.013-16 μg/l for fluconazole and amphotericin B, respectively. The final inoculum concentration ranged from 0.5 ×10 3 to 2.5 ×10 3 cells/ml. Testing was performed in 96-well round-bottomed microtiter plates and was incubated at 35°C for 48-72 h. The minimum inhibitory concentration (MIC) of fluconazole and amphotericin B was read as the lowest concentration of the agent, which inhibited growth by 50% and 80%, respectively. 
Statistical analysis
Frequency distributions were obtained and percentages were calculated accordingly. GraphPad Inc. statistical software (2236 Avenida de la Playa, La Jolla, CA 92037, USA) was used for the calculation of P value using Fisher's exact test and one-sample t-test as applicable. Statistical significance was defined as P < 0.05.
RESULTS
A total of 153 CSF samples (31 females and 122 males) were collected from patients suspected to be suffering from meningitis. Nineteen (12.4%) were positive for C. neoformans infection by antigen detection, direct microscopic examination (India ink preparation), and culture. Age range and mean age of the 19 patients were 2-78 years and 34 years, respectively, with male predominance (18 males and 1 female), which was statistically significant (P = 0.00303). Of the 19 patients, 17 (89.5%) were HIV reactive and 2 (10.5%) were HIV nonreactive. Both HIV nonreactive samples belonged to male patients. Mortality rate was 42.11% (8 out of 19) in cases of meningitis.
Hematological and cerebrospinal fl uid parameters
The mean total leukocyte count of the 19 study participants was 5478 cells/μL, which is within the normal range (4000-11,000 cells/μL). However, the mean hemoglobin level was much lesser at 8.51 g/dl and was statistically significantly (P < 0.0001) different from normal hemoglobin levels (13-16 g/dl), while mean blood urea level was raised (53.57 mg/dl) than the normal (15.2 mg/dl). CSF analysis revealed normal protein levels (mean protein = 42.67 mg/dl) and low glucose (mean glucose = 35 mg/dl; normal CSF glucose = 45-80 mg/dl, P = 0.0001) levels.
Susceptibility of study isolates to antifungals
Eighteen (94.74%) strains were susceptible to amphotericin B (both by MIC and E-strip). Fluconazole was reported susceptible in 15 (78.95%), susceptible but dose-dependent in 3 (15.79%), and resistant in 1 (5.26%) strain as per the CLSI guidelines [ Table 1 ]; however, by E-strip, all strains were in the susceptible zone. Both HIV nonreactive samples were susceptible to fluconazole and amphotericin B, while among the HIV reactive samples, 13 (76%) and 16 (94%) were susceptible to fluconazole and amphotericin B, respectively.
DISCUSSION
The present study shows that though the number of new HIV infections has dropped drastically from 2.51 lakhs in 2000 to 86,000 in 2015, C. neoformans still remains the primary opportunistic infection in AIDS patients. [8] Most of the cases were in the age group of 28-50 years. This is in accordance with the national level statistics published by the National AIDS Control Organisation (NACO) in 2015. [8] Males predominated the study group in statistically significant numbers. This finding is also in agreement with the national level statistics published by NACO in 2015. [8] Disparity in the gender distribution may be due to difference in exposure and not in susceptibility. [9] However, in a few instances, females have also been found to be affected with cryptococcal meningitis more often than males. [1] The study participants had low blood hemoglobin levels, which was statistically significant and is a known feature of persistent cryptococcal meningitis. [10] Blood urea was also raised in them which is another recognized feature of cryptococcal meningitis. [11] Hypoglycorrhachia, a known poor prognostic marker of cryptococcal meningitis, was seen in most of the patients in statistically significant levels, which is similar to the previous studies. [11, 12] Resistance to fluconazole was encountered in almost one-fourth of HIV-seropositive individuals, while amphotericin B resistance was detected at a much lower level (6%), conforming to prior studies. [13] Amphotericin B, fluconazole, and flucytosine are used in the treatment of cryptococcal meningitis, irrespective of coexisting HIV status. [3] Flucytosine is not commonly used in India because of its unavailability and high price. [3, 12] Combination of amphotericin B and flucytosine is recommended initially for the first 2 weeks, after which fluconazole is started. [11, 14] Resistance of C. neoformans to fluconazole and amphotericin B has been reported in previous studies as well. [15] Nonetheless, unlike fluconazole-resistant candidiasis, fluconazole-resistant cryptococcosis is not widely recorded. [15] The present study adds to the limited number of studies on this aspect. Surfacing of resistance to fluconazole suggests the need for alertness and extensive surveillance of chemosensitivity of clinical isolates at regular intervals. [3] As resistance to amphotericin B still has not reached dangerous proportions, its use must be restricted to prevent any further increase. Since cryptococcal meningitis is usually considered rare in immunocompetent individuals, specific treatment is not administered until the organism is identified or cryptococcal antigen is detected from the specimen. [3] Hence, despite the availability of newer antifungal agents, cryptococcosis in HIV-negative patients is often associated with considerable morbidity and mortality. [3] CONCLUSIONS Our study demonstrates that C. neoformans should be suspected as a possible cause of meningitis even in HIV-negative patients. Resistance to amphotericin B was seen in much lesser number of isolates compared to fluconazole. Hence, use of amphotericin B for treating C. neoformans infection must be limited to avert further rise in resistance. Early diagnosis of cryptococcal meningitis and initiation of appropriate therapy are imperative as it will lead to improved clinical outcome and a better prognosis with lesser relapse rate.
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